Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB26FXYGX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,315
Award facts
- Contract value 100% obligated
- $11,314.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ondansetron HCl 4 mg tablets in a quantity of 500 units. This firm fixed-price delivery order, valued at $11,314.59, is not associated with any set-aside designation and represents a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company's pharmaceutical supply chain relationship with DLA enables it to deliver a comprehensive range of medications and medical supplies across multiple therapeutic domains in support of Defense Health Agency operations and other government healthcare systems. Ondansetron, an anti-nausea medication commonly used in medical settings, is among the various pharmaceutical products the company supplies through its federal contracts. AmerisourceBergen's extensive portfolio of competitively awarded delivery orders demonstrates its capability to fulfill diverse federal medical procurement requirements with firm fixed pricing arrangements.
Quick answers
Who was awarded contract SPE2DB26FXYGX?
SPE2DB26FXYGX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FXYGX worth?
The government has obligated $11,315 on SPE2DB26FXYGX.
Is contract SPE2DB26FXYGX an order under another contract?
Yes. SPE2DB26FXYGX is a delivery order under SPE2DB25D7055, an indefinite delivery contract.
Was contract SPE2DB26FXYGX competed?
The extent of competition for SPE2DB26FXYGX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award